精优药业：郭懿获委任为行政总裁
EXTRAWELL PHAREXTRAWELL PHAR(HK:00858) Zhi Tong Cai Jing·2025-12-30 12:18

Group 1 - The company, 精优药业 (00858), announced a leadership change effective January 1, 2026, to enhance corporate governance and meet development needs [1] - Dr.谢毅 will resign as CEO to focus on formulating company strategy but will continue as Chairman of the Board and Executive Director [1] - Dr.郭懿 will be appointed as the new CEO [1]